XORTX Therapeutics, Inc. (XRTX)
0.89
-0.17
(-16.04%)
USD |
NASDAQ |
Nov 19, 16:00
0.8722
-0.02
(-2.00%)
Pre-Market: 09:27
XORTX Therapeutics Free Cash Flow : -5.174M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -5.174M |
| June 30, 2026 | -5.239M |
| March 31, 2026 | -2.688M |
| December 31, 2025 | -2.830M |
| September 30, 2025 | -2.952M |
| June 30, 2025 | -3.083M |
| March 31, 2025 | -2.991M |
| December 31, 2024 | -3.651M |
| September 30, 2024 | -4.135M |
| June 30, 2024 | -4.443M |
| March 31, 2024 | -5.430M |
| December 31, 2023 | -6.628M |
| September 30, 2023 | -9.135M |
| June 30, 2023 | -9.009M |
| March 31, 2023 | -9.155M |
| December 31, 2022 | -9.157M |
| Date | Value |
|---|---|
| September 30, 2022 | -8.492M |
| June 30, 2022 | -7.610M |
| March 31, 2022 | -6.437M |
| December 31, 2021 | -4.855M |
| September 30, 2021 | -1.681M |
| June 30, 2021 | -1.703M |
| March 31, 2021 | -1.135M |
| December 31, 2020 | -0.548M |
| September 30, 2020 | -0.5993M |
| June 30, 2020 | -0.4991M |
| March 31, 2020 | -0.3889M |
| December 31, 2019 | -0.1403M |
| September 30, 2019 | -0.2109M |
| June 30, 2019 | -0.3769M |
| March 31, 2019 | -0.5577M |
| December 31, 2018 | -0.7486M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lexaria Bioscience Corp. | -7.527M |
| Target Group, Inc. (Canada) | -0.4005M |
| NervGen Pharma Corp. | -23.77M |
| Milestone Pharmaceuticals, Inc. | -76.02M |
| Appili Therapeutics, Inc. | -0.971M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.5428M |
| Cash from Investing (Quarterly) | -0.033M |
| Cash from Financing (Quarterly) | -0.0951M |
| Free Cash Flow Per Share (Quarterly) | -0.3194 |
| Free Cash Flow to Equity (Quarterly) | -0.5758M |
| Free Cash Flow to Firm (Quarterly) | -0.5758M |
| Free Cash Flow Yield | -305.6% |